Evidence map›Paper›PMID 31980459›Full record

ArticleThe Journal of biological chemistry2020

High-resolution crystal structures of two prototypical β- and γ-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity.

Yves A Muller, Sigrun Häge, Sewar Alkhashrom, Tobias Höllriegl, Sebastian Weigert, Simon Dolles, Kerstin Hof, Sascha A Walzer, Claudia Egerer-Sieber, Marcus Conrad and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Yves A MullerDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany. Electronic address: yves.muller@fau.de.
Sigrun HägeInstitute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg, Medical Center, Erlangen, Germany.
Sewar AlkhashromDepartment of Chemistry and Pharmacy, Division of Medicinal Chemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Tobias HöllrieglDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Sebastian WeigertDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Simon DollesDepartment of Chemistry and Pharmacy, Division of Medicinal Chemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Kerstin HofDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Sascha A WalzerDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Claudia Egerer-SieberDepartment of Biology, Division of Biotechnology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Marcus ConradDivision of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Stephanie HolstDepartment of Chemistry and Pharmacy, Division of Medicinal Chemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Josephine LösingInstitute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg, Medical Center, Erlangen, Germany.
Eric SonntagInstitute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg, Medical Center, Erlangen, Germany.
Heinrich StichtDivision of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Jutta EichlerDepartment of Chemistry and Pharmacy, Division of Medicinal Chemistry, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Manfred MarschallInstitute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg, Medical Center, Erlangen, Germany. Electronic address: manfred.marschall@fau.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpesviruses uniquely express two essential nuclear egress-regulating proteins forming a heterodimeric basic structure of the nuclear egress complex (core NEC). These core NECs serve as a hexameric lattice-structured platform for capsid docking and recruit viral and cellular NEC-associated factors that jointly exert nuclear lamina- and membrane-rearranging functions (multicomponent NEC). Here, we report the X-ray structures of β- and γ-herpesvirus core NECs obtained through an innovative recombinant expression strategy based on NEC-hook::NEC-groove protein fusion constructs. This approach yielded the first structure of γ-herpesviral core NEC, namely the 1.56 Å structure of Epstein-Barr virus (EBV) BFRF1-BFLF2, as well as an increased resolution 1.48 Å structure of human cytomegalovirus (HCMV) pUL50-pUL53. Detailed analysis of these structures revealed that the prominent hook segment is absolutely required for core NEC formation and contributes approximately 80% of the interaction surface of the globular domains of NEC proteins. Moreover, using HCMV::EBV hook domain swap constructs, computational prediction of the roles of individual hook residues for binding, and quantitative binding assays with synthetic peptides presenting the HCMV- and EBV-specific NEC hook sequences, we characterized the unique hook-into-groove NEC interaction at various levels. Although the overall physicochemical characteristics of the protein interfaces differ considerably in these β- and γ-herpesvirus NECs, the binding free energy contributions of residues displayed from identical positions are similar. In summary, the results of our study reveal critical details of the molecular mechanism of herpesviral NEC interactions and highlight their potential as an antiviral drug target.

Indexed as

Amino Acid SequenceBetaherpesvirinaeCrystallography, X-RayCytomegalovirusGammaherpesvirinaeHeLa CellsHerpesvirus 4, HumanHumansPeptidesProtein Structure, TertiaryRecombinant Fusion ProteinsSurface Plasmon ResonanceViral ProteinsPeptidesRecombinant Fusion ProteinsViral Proteinsalanine scanconfocal microscopycrystal structureenergeticsEpstein-Barr virusherpesvirusHuman cytomegalovirusnuclear egress complexProtein-protein interactionsstructure-function

Identifiers

PMID31980459
PMCPMC7062154
OpenAlexW3002940181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.